Company Encyclopedia
View More
name
Owlet
OWLT.US
Owlet, Inc. provides digital parenting solutions in the United States, the United Kingdom, and internationally. The company offers a digital parenting platform that provides real-time data and insights to parents. It also provides sock monitors, including Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology that tracks vital signs, such as pulse rate, activity, oxygen level, and sleep patterns; BabySat, which is intended for infants with conditions, including respiratory syncytial virus, pneumonia, bronchitis, croup, and other diagnoses; and Owlet Smart Sock, which provides real-time heart rate and oxygen readings in the Owlet Care App.
1.366 T
OWLT.USMarket value -Rank by Market Cap -/-

Financial Score

21/11/2025 Update
C
Health Care EquipmentIndustry
Industry Ranking71/170
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE97.76%A
    • Profit Margin-39.68%E
    • Gross Margin50.64%B
  • Growth ScoreB
    • Revenue YoY26.81%A
    • Net Profit YoY-231.17%E
    • Total Assets YoY33.38%A
    • Net Assets YoY-213.77%E
  • Cash ScoreC
    • Cash Flow Margin-269.64%D
    • OCF YoY26.81%A
  • Operating ScoreA
    • Turnover1.52A
  • Debt ScoreE
    • Gearing Ratio157.43%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Owlet Partners with Locus Health to Streamline Infant Health Data for Remote Monitoring

    Owlet Inc. has partnered with Locus Health to integrate data from Owlet’s BabySat® device into Locus Health's platform, enhancing remote monitoring of infant health post-hospital discharge. This collaboration aims to improve care continuity and support families during the transition from hospital to home by allowing clinicians to track vital signs remotely.

    Reuters·
    US
    OWLT
    -3.94%
    Reuters·
    US
    OWLT
    -3.94%

    From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying?

    The biotech sector is experiencing significant growth, with stocks like Olema, Owlet, Rigel, Jazz, and Terns Pharmaceuticals reaching new highs. Key developments include Olema's public offering plans, Owlet's strong Q3 revenue, Rigel's positive trial data, Jazz's successful Phase 3 trial, and Terns' updated Phase 1 data. Investors are advised to discern between short-term price action and long-term value in this volatile market.

    rttnews·
    US
    OWLT
    -3.94%
    US
    OLMA
    +13.28%
    US
    TERN
    -3.72%
    rttnews·
    US
    OWLT
    -3.94%
    US
    OLMA
    +13.28%
    US
    TERN
    -3.72%

    Owlet Inc. unveils investor presentation highlighting pediatric health platform and product leadership

    Owlet Inc. (NYSE: OWLT) has released an investor presentation highlighting its leadership in the pediatric health platform market. The presentation showcases Owlet as the first FDA-cleared baby monitor provider, leading in market share by dollar value. It emphasizes the Dream Sock product for real-time infant health insights and includes customer testimonials and leadership details. The presentation is available online, and the content was originally published by Owlet Inc. on November 17, 2025.

    Reuters·
    US
    OWLT
    -3.94%
    Reuters·
    US
    OWLT
    -3.94%

    Owlet Inc. Achieves Record Revenue and Global Growth

    Owlet Inc. reported record Q3 2025 revenue of $32 million, a 45% increase from Q3 2024, with a gross profit of $16.2 million. The company achieved FDA clearance for its DreamSock product, expanded globally, and formed a strategic partnership with Rhapsody. Despite tariff challenges, Owlet raised its 2025 revenue forecast to $103-$106 million, projecting 32%-36% growth. The company completed a warrant exchange and equity offering, raising $32 million. Owlet's strong performance and strategic initiatives suggest continued growth despite consumer environment uncertainties.

    Tip Ranks·
    US
    OWLT
    -3.94%
    Tip Ranks·
    US
    OWLT
    -3.94%

    Lake Street Reaffirms Their Buy Rating on Owlet (OWLT)

    Lake Street's Ben Haynor reaffirmed a Buy rating on Owlet with a $13.00 price target. Haynor, who covers the Healthcare sector, has an average return of -15.3% and a 27.75% success rate. Northland Securities also issued a Buy rating, while TR | OpenAI reiterated a Hold rating on Owlet.

    Tip Ranks·
    US
    OWLT
    -3.94%
    Tip Ranks·
    US
    OWLT
    -3.94%